Category: Company News
-

Generation Income Properties Cuts Loci Preferred Equity Balance to About $4 Million After Asset Sales
Generation Income Properties (NASDAQ:GIPR) has continued its debt reduction strategy with two non-core property sales expected to direct approximately $4.04 million toward its Loci Capital preferred equity redemption obligation, reducing the balance to approximately $4 million from roughly $20 million in 2025. Key Investor Takeaways Why GIPR Stock Is in Focus Generation Income Properties has…
-

Alpha Modus Patent Challenge Denied, Advancing MNTN Infringement Case
Alpha Modus Holdings (NASDAQ:AMOD) has cleared an early hurdle in its patent enforcement campaign after a federal court denied MNTN’s attempt to dismiss an infringement lawsuit involving three Alpha Modus patents, allowing the case to advance toward claim construction and discovery. Key Investor Takeaways Why AMOD Stock Is in Focus The U.S. District Court for…
-

Recon Technology Wins RMB 9.6 Million Oilfield Digitalization Project
Recon Technology (NASDAQ:RCON) has won multiple sections of an oilfield digitalization project worth approximately RMB 9.6 million, or US$1.33 million, extending the company’s presence in production informatization and automation services for China’s oil and gas industry. Key Investor Takeaways Why RCON Stock Is in Focus Recon’s affiliated entity, Nanjing Recon Technology Co., won multiple bid…
-

Jazz Pharmaceuticals Wins FDA Approval for Ziihera Regimens in First-Line HER2+ Advanced GEA
Jazz Pharmaceuticals (NASDAQ:JAZZ) has secured FDA approval for two Ziihera-containing regimens in first-line HER2-positive advanced gastroesophageal adenocarcinoma, expanding the drug into an earlier treatment setting after Phase 3 data showed improvements in progression-free and overall survival. Key Investor Takeaways Why JAZZ Stock Is in Focus The Ziihera FDA approval gives Jazz two new first-line regimens…
-

Anavex Life Sciences Advances Alzheimer’s Phase 3 Planning as Cash Runway Extends Into Fiscal 2028
Anavex Life Sciences (NASDAQ:AVXL) is advancing Alzheimer’s Phase 3 planning with the FDA after submitting its clinical trial data to a newly opened Alzheimer’s IND, while reporting $118.3 million in cash and an expected operating runway into mid to late fiscal 2028. Key Investor Takeaways Why AVXL Stock Is in Focus Anavex’s near-term regulatory strategy…
-

Lavish Enterprises Introduces FleetPath Ace Autonomous Trucking Operator Ahead of Beta Testing
Lavish Enterprises (USOTC:VXIT) has introduced FleetPath Ace, an autonomous trucking operator designed to perform defined operational tasks across dispatch, billing, safety, maintenance, finance and other carrier functions, with live autonomous execution planned as part of FleetPath’s beta rollout. Key Investor Takeaways Why VXIT Stock Is in Focus FleetPath Ace represents an expansion of FleetPath from…
-

Hyperscale Data Bitcoin Treasury Reaches Approximately $21.6 Million
Hyperscale Data (AMEX:GPUS) reported 278.0314 Bitcoin valued at approximately $21.6 million as of August 23, 2026, while making no open-market Bitcoin purchases or sales during the latest week. Key Investor Takeaways Why GPUS Stock Is in Focus Hyperscale Data said its wholly owned subsidiaries Sentinum and Ault Capital Group collectively held 278.0314 Bitcoin as of…
-

American Fusion Reaches 100 Pending Patent Applications for Texatron Fusion Platform
American Fusion Inc. (USOTC:AMFN) has reached 100 pending patent applications covering its Texatron Fusion Engine platform after filing 17 additional U.S. applications, expanding the intellectual property portfolio surrounding its developing fusion technology. The latest filings focus largely on aluminum-based configurations and alternative structural designs, extending protection across areas including fusion-confinement structures, toroidal chambers, fuel-injection systems,…
-

Xeriant Positions NexBoard as Universal Construction Panel After Independent Testing
Xeriant, Inc. (USOTC:XERI) is positioning its NexBoard composite panel as a universal construction material capable of replacing several traditional building products after independent laboratory testing showed performance advantages across multiple categories. The company says NexBoard could potentially serve applications ranging from interior walls and ceilings to subflooring, roofing underlayment and exterior sheathing, broadening the commercial…
-

American EcoFuels Launches Phase 2 Patent Expansion for GTL and CTL Technologies
American EcoFuels Inc. (USOTC:AEFI) has launched a Phase 2 patent expansion programme that currently contemplates up to 584 additional applications covering its Gas-to-Liquids and Coal-to-Liquids technology platforms. The intellectual property initiative is designed to broaden protection around the company’s synthetic fuel technologies as American EcoFuels advances toward engineering, testing, certification and potential commercialisation of Sustainable…